Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Isoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] | ||
Ligand | BDBM585804 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Cbl-b Displacement Assay (Cbl-b Inhibition Assay low) | ||
IC50 | <1±n/a nM | ||
Citation | Sands, AT; Bence, NF; Zapf, CW; Cohen, F; Wang, C; Cummins, T; Tanaka, H; Shunatona, H; Cardozo, M; Weiss, D; Gosling, J Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof US Patent US11530229 Publication Date 12/20/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
Isoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] | |||
Name: | Isoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] | ||
Synonyms: | CBLB | CBLB_HUMAN | E3 ubiquitin-protein ligase CBL-B [36-427] | RNF56 | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 45487.32 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 36-427 (sequence in paper SEQ ID No: 1) | ||
Residue: | 392 | ||
Sequence: |
| ||
BDBM585804 | |||
n/a | |||
Name | BDBM585804 | ||
Synonyms: | US11530229, Compound 19 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H33F3N6O | ||
Mol. Mass. | 562.6285 | ||
SMILES | C[C@H]1CCCN(Cc2cc3C(=O)N(Cc3c(c2)C(F)(F)F)c2cccc(c2)[C@@]2(Cc3nncn3C)C[C@@H](C2)C#N)C1 |r,wU:36.42,wD:27.29,1.0,(-10.75,-3.13,;-9.21,-3.13,;-8.44,-4.47,;-6.9,-4.47,;-6.13,-3.13,;-6.9,-1.8,;-6.13,-.47,;-4.59,-.47,;-3.82,.87,;-2.28,.87,;-1.25,2.01,;-1.57,3.52,;.16,1.39,;-0,-.15,;-1.51,-.47,;-2.28,-1.8,;-3.82,-1.8,;-1.51,-3.13,;-2.28,-4.47,;.03,-3.13,;-.74,-4.47,;1.49,2.16,;1.49,3.7,;2.82,4.47,;4.16,3.7,;4.16,2.16,;2.82,1.39,;5.49,1.39,;4.16,.62,;4.16,-.92,;2.91,-1.83,;3.39,-3.29,;4.93,-3.29,;5.4,-1.83,;6.87,-1.35,;6.58,.3,;7.67,1.39,;6.58,2.48,;9.21,1.39,;10.75,1.39,;-8.44,-1.8,)| | ||
Structure |